Analysis date: 12.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 02.12.2025.
Interest
Very weak
Very weak
One star since 21.11.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 07.11.2025 at a price of 6.52.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 18.07.2025.
4wk Rel Perf
0.18%
0.18%
The four-week dividend-adjusted performance versus STOXX600 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 02.12.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.06%.
Mkt Cap in $bn
1.01
1.01
With a market capitalization <$2bn, CORTICEIRA AMORIM is considered a small-cap stock.
G/PE Ratio
1.30
1.30
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
13.70
13.70
The estimated PE is for the year 2027.
LT Growth
12.90%
12.90%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
6
6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
4.84%
4.84%
The twelve month estimated dividend yield represents 66.31% of earnings forecasts.
Beta
59
59
For 1% of index variation, the stock varies on average by 0.59%.
Correlation
0.44
0.44
44.43% of stock movements are explained by index variations.
Value at Risk
0.82
0.82
The value at risk is estimated at EUR 0.82. The risk is therefore 12.44%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
26.04.2019
26.04.2019